DEZHAN HEALTHCARE(SZ:000813)2016-08-26 16:00Financial Performance - The company's operating revenue for the first half of 2016 was ¥190,662,689.51, a decrease of 20.78% compared to ¥240,659,925.75 in the same period last year[21]. - The net profit attributable to shareholders of the listed company was a loss of ¥22,138,946.53, a decline of 496.28% from a profit of ¥5,586,652.28 in the previous year[21]. - Basic earnings per share were reported at -¥0.0474, a decrease of 495.00% compared to ¥0.0120 in the same period last year[21]. - The total operating revenue for the first half of 2016 was CNY 190,662,689.51, a decrease of 20.8% compared to CNY 240,659,925.75 in the same period of 2015[123]. - The total operating costs amounted to CNY 200,711,691.22, slightly down from CNY 204,771,645.10, resulting in an operating loss of CNY -8,507,300.41 compared to a profit of CNY 35,888,280.65 in the previous year[123]. - The company reported a total comprehensive loss of CNY 42,570,123.20, compared to a loss of CNY 29,843,883.15 in the previous period[128]. Cash Flow and Liquidity - The net cash flow from operating activities increased by 129.38% to ¥42,781,351.32, compared to ¥18,650,883.54 in the same period last year[21]. - The total cash inflow from operating activities was CNY 251,727,296.38, a decrease of 6.8% compared to CNY 270,154,586.62 in the previous period[130]. - The cash and cash equivalents at the end of the period stood at CNY 145,770,606.97, compared to CNY 91,203,706.93, reflecting a significant increase of 60%[132]. - The total cash outflow for investment activities was CNY 41,712,134.74, up from CNY 19,205,699.00, indicating a rise of 117%[131]. - The net cash flow from investment activities was CNY -37,988,643.13, worsening from CNY -18,179,699.00 in the previous period[131]. Assets and Liabilities - The total assets at the end of the reporting period were ¥1,990,272,143.12, reflecting a slight increase of 0.91% from ¥1,972,266,539.18 at the end of the previous year[21]. - The total liabilities amounted to CNY 632,867,104.14, up from CNY 599,395,638.93, which is an increase of approximately 5.6%[115]. - The company's equity totaled CNY 1,357,405,038.98, down from CNY 1,372,870,900.25, reflecting a decrease of about 1.1%[116]. - Current assets totaled CNY 372,538,434.81 at the end of the reporting period, up from CNY 366,417,749.58, indicating a growth of about 1.2%[114]. - The company's total assets decreased to CNY 1,324,072,455.39 from CNY 1,382,802,527.64, indicating a reduction of approximately 4.2%[120]. Shareholder Information - The total number of shares outstanding is 467,495,300, with 22.26% being restricted shares and 77.74% being unrestricted shares[95]. - The largest shareholder, Xinjiang Kaidi Investment Co., Ltd., holds 30.24% of the shares, totaling 141,354,457 ordinary shares[97]. - The total number of shareholders at the end of the reporting period is 19,647[97]. - The company has not reported any changes in the number of shares or shareholder structure that would affect earnings per share or net asset value per share[95]. Governance and Compliance - The company has a well-structured governance system, including a board of directors with 9 members, 3 of whom are independent directors[59]. - The company has maintained its independence and governance structure as per regulatory requirements[82]. - The financial report does not include any commitments regarding future plans or development strategies, highlighting the need for investors to be aware of investment risks[6]. - The half-year financial report was not audited[85]. Business Operations - The textile segment generated operating revenue of CNY 76.08 million, with a gross margin of 10.00%, while the mining segment reported CNY 109.73 million in revenue, with a gross margin of 39.63%[34]. - The company completed the relocation of its textile subsidiary to the Tianshan Textile Industrial Park, which is now fully operational[33]. - The mining division has completed 60.91% of the deep mining project and has made significant progress in the filling system project[33]. - Domestic sales increased by 32.11% to CNY 157.60 million, while foreign sales rose by 1.70% to CNY 28.59 million[37]. Investment and Restructuring - The company completed a major asset restructuring, exchanging assets valued at 798.75 million with Merrylin Holdings for a 47.72% stake in Jialin Pharmaceutical[88]. - The restructuring was approved by the China Securities Regulatory Commission (CSRC) on July 29, 2016[90]. - The company has received approval for its major asset restructuring from the Xinjiang State-owned Assets Supervision and Administration Commission and the China Securities Regulatory Commission[29]. Research and Development - Research and development expenses decreased by 67.11% to CNY 221,779, reflecting a reduction in investment in this area[31]. - The company has not conducted any research, communication, or interview activities during the reporting period[56]. Risk Management - The company has established a hedging system for futures trading to mitigate price fluctuation risks[46]. - The company has implemented strict internal controls and management for its hedging activities to ensure compliance with regulations[46].